An analysis of FDA-approved drugs for infectious disease: antibacterial agents von Kinch, Michael S., Patridge, Eric, Plummer, Mark, Hoyer, Denton

Volltext

Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry von Kinch, Michael S., Moore, Ryan

Volltext

An analysis of FDA-approved drugs: natural products and their derivatives von Patridge, Eric, Gareiss, Peter, Kinch, Michael S., Hoyer, Denton

Volltext

WANTED DEAD OR ALIVE: New Thinking to Incentivize Drug Development von Kinch, Michael S.

Volltext

Monoclonal antibodies: Trends in therapeutic success and commercial focus von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

Fiduciary responsibility von Kinch, Michael S.

Volltext

The pharmaceutical innovator’s dilemma von Kinch, Michael S.

Volltext

Keeping apace on the pharmaceutical treadmill von Kinch, Michael S

Volltext

An analysis of FDA-approved drugs for oncology von Kinch, Michael S.

Volltext

An overview of FDA-approved new molecular entities: 1827–2013 von Kinch, Michael S., Haynesworth, Austin, Kinch, Sarah L., Hoyer, Denton

Volltext

An analysis of FDA-approved drugs for cardiovascular diseases von Kinch, Michael S., Surovtseva, Yulia, Hoyer, Denton

Volltext

Antibiotic Development: Lessons from the Past and Future Opportunities von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

2023 in review: FDA approvals of new medicines von Kinch, Michael S, Kraft, Zachary, Schwartz, Tyler

Volltext

2022 in review: FDA approvals of new medicines von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

2021 in review: FDA approvals of new medicines von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

Sources of innovation for new medicines: questions of sustainability von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

2020 in review: FDA approvals of new medicines von Kinch, Michael S., Kraft, Zachary, Schwartz, Tyler

Volltext

Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection von WARREN, Travis K, WARFIELD, Kelly L, BAVARI, Sina, WELLS, Jay, ENTERLEIN, Sven, SMITH, Mark, RUTHEL, Gordon, YUNUS, Abdul S, KINCH, Michael S, GOLDBLATT, Michael, JAVAD AMAN, M

Volltext

A reconsideration of university gap funds for promoting biomedical entrepreneurship von Hall, Everett G., Krenning, Thomas M., Reardon, Robert J., Toker, Emre, Kinch, Michael S.

Volltext